Literature DB >> 20442813

Introduction: disease overview and risk factors.

.   

Abstract

Year:  2010        PMID： 20442813      PMCID： PMC2851494     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  23 in total

Review 1.  Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.

Authors:  Jutta K Preiksaitis; Daniel C Brennan; Jay Fishman; Upton Allen
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

Review 2.  Cytomegalovirus.

Authors: 
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

Review 3.  Management of CMV infection and disease in transplant patients. 27-29 February 2004.

Authors:  Raymund R Razonable; Vincent C Emery
Journal:  Herpes       Date:  2004-12

Review 4.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations.

Authors:  Martin R Zamora; R Duane Davis; Colm Leonard
Journal:  Transplantation       Date:  2005-07-27       Impact factor: 4.939

Review 6.  Definitions of cytomegalovirus infection and disease in transplant recipients.

Authors:  Per Ljungman; Paul Griffiths; Carlos Paya
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

7.  Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone.

Authors:  H A Valantine; H Luikart; R Doyle; J Theodore; S Hunt; P Oyer; R Robbins; G Berry; B Reitz
Journal:  Transplantation       Date:  2001-11-27       Impact factor: 4.939

Review 8.  Etiology and impact of cytomegalovirus disease on solid organ transplant recipients.

Authors:  Lisa M McDevitt
Journal:  Am J Health Syst Pharm       Date:  2006-10-01       Impact factor: 2.637

Review 9.  Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients.

Authors:  Florencia Pereyra; Robert H Rubin
Journal:  Curr Opin Infect Dis       Date:  2004-08       Impact factor: 4.915

10.  Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction.

Authors:  David Weill; Brion J Lock; Donavon L Wewers; K Randall Young; George L Zorn; Lesley Early; James K Kirklin; David C McGiffin
Journal:  Am J Transplant       Date:  2003-04       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.